Exercise Training for Heart Failure
Trial Summary
What is the purpose of this trial?
The heart failure syndrome that occurs when the heart is too sick to properly do its job. One of the main symptoms is difficulty with exercise. One way to improve symptoms is to start patients in a 12 week exercise program called cardiac rehabilitation. Cardiac rehabilitation been shown to improve symptoms for heart failure patients. However, the investigators do not know exactly what exercise does to the molecules that make up the human body. If the investigators could answer this question, the investigators might find a whole new way to treat the symptoms of heart failure. Therefore the investigators want to know what molecules might be responsible for the benefits of exercise. The plan for this study is to measure the levels of thousands of proteins in blood samples which come from people with heart failure and see how those levels change after 12 weeks of cardiac rehabilitation, compared to the protein levels in patients whose cardiac rehabilitation is delayed until after the study period. If the investigators know the proteins that change with exercise, the investigators can then look to see if targeting these proteins with medicines can mimic the benefits of exercise. The long term goal of our work is to identify "exercise-in-a-pill" medicines that will help people with heart failure.
Will I have to stop taking my current medications?
The trial requires participants to stop taking certain medications, including steroids, insulin, and some psychiatric drugs. If you're on any of these, you may need to stop or adjust them before joining the study.
What data supports the effectiveness of the treatment for heart failure?
Research shows that cardiac rehabilitation, which includes exercise training, can improve exercise tolerance, reduce symptoms, and enhance quality of life for heart failure patients. It also helps reduce hospitalizations and improve heart function, making it a beneficial part of heart failure management.12345
Is exercise training safe for heart failure patients?
How does cardiac rehabilitation differ from other treatments for heart failure?
Cardiac rehabilitation is unique because it combines exercise training with lifestyle changes and psychological support, improving heart function and quality of life without medication. Unlike drug treatments, it focuses on physical activity tailored to each patient's tolerance, aiming to enhance overall health and reduce heart-related complications.25101112
Research Team
Daniel H Katz, MD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for adults aged 18-89 with heart failure where the heart's pumping power is reduced (ejection fraction <40%). Participants must be willing to undergo cardiac rehabilitation and not be pregnant, planning pregnancy, or have given birth in the last year. They should not be on certain medications that could affect the study results or have had recent psychiatric hospitalizations.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Acute Exercise and Blood Sampling
Participants undergo a 40-minute bout of moderate intensity exercise with blood samples collected before and after at 10, 30, and 210 minutes.
Cardiac Rehabilitation
Participants engage in a 12-week exercise program called cardiac rehabilitation.
Follow-up
Participants are monitored for changes in proteomic profiles and cardiopulmonary fitness after the intervention.
Treatment Details
Interventions
- Cardiac rehabilitation
Cardiac rehabilitation is already approved in European Union, United States, Canada, Japan for the following indications:
- Heart failure
- Coronary artery disease
- Post-myocardial infarction
- Heart failure
- Coronary artery disease
- Post-myocardial infarction
- Chronic obstructive pulmonary disease
- Heart failure
- Coronary artery disease
- Post-myocardial infarction
- Heart failure
- Coronary artery disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
American Heart Association
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator